| 1.
|
In reference to the indications for positron imaging, discuss why this
type of nuclear medicine study would be preferable to, or complement
other nuclear medicine procedures or diagnostic modalities in various
cases. (I)
|
| 2.
|
Describe the radiopharmaceuticals used for positron imaging including
the physical and chemical properties, biorouting, dose preparation,
and route and method of administration. (I)
|
| 3.
|
Discuss the physical or pathological conditions or medications that
could contraindicate or interfere with positron imaging. (I)
|
| 4.
|
Describe precautions and potential adverse reactions to
radiopharmaceuticals. (I)
|
| 5.
|
Related dose range for positron imaging and the resulting radiation
dose to various organs and tissues. (I)
|
| 6.
|
Describe the preparation of the patient for positron imaging. (II)
|
| 7.
|
Describe the procedures for positron imaging including equipment,
protocol, dose and administration technique,
administration-to-acquisition times, acquisition parameters, standard
positioning and views, and special imaging adaptations. (III)
|
| 8.
|
Describe the procedure for data processing and image formatting. (III)
|
| 9.
|
Identify and potential pitfalls with basic procedure and processing.
(III)
|
| 10.
|
Compare and contrast selected interventions and procedures including
vasodilators, psychological stress studies, and sensory stimulation
studies. (IV)
|
| 11.
|
Describe the normal distribution and normal variants seen in positron
imaging as recognized on printed images. (V)
|
| 12.
|
Describe various artifacts that can occur during positron imaging as
identified on printed images. (V)
|
| 13.
|
Discuss common causes of false-negative and false positive positron
imaging. (V)
|
| 14.
|
Discuss the diagnostic and prognostic value of positron imaging. (VI)
|
|